Abstract
The utility of human pluripotent stem cells is dependent on efficient differentiation protocols that convert these cells into relevant adult cell types. Here we report the robust and efficient differentiation of human pluripotent stem cells into white or brown adipocytes. We found that inducible expression of PPARG2 alone or combined with CEBPB and/or PRDM16 in mesenchymal progenitor cells derived from pluripotent stem cells programmed their development towards a white or brown adipocyte cell fate with efficiencies of 85%–90%. These adipocytes retained their identity independent of transgene expression, could be maintained in culture for several weeks, expressed mature markers and had mature functional properties such as lipid catabolism and insulin-responsiveness. When transplanted into mice, the programmed cells gave rise to ectopic fat pads with the morphological and functional characteristics of white or brown adipose tissue. These results indicate that the cells could be used to faithfully model human disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
206,07 € per year
only 17,17 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout







Similar content being viewed by others
References
Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145–1147 (1998).
Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).
Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007).
Park, I. H. et al. Disease-specific induced pluripotent stem cells. Cell 134, 877–886 (2008).
Lee, G. et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461, 402–406 (2009).
Green, H. & Kehinde, O. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 5, 19–27 (1975).
Farmer, S. R. Transcriptional control of adipocyte formation. Cell Metab. 4, 263–273 (2006).
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I. & Spiegelman, B. M. mPPAR γ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8, 1224–1234 (1994).
Tontonoz, P., Hu, E. & Spiegelman, B. M. Stimulation of adipogenesis in fibroblasts by PPAR γ2, a lipid-activated transcription factor. Cell 79, 1147–1156 (1994).
Cannon, B. & Nedergaard, J. Brown adipose tissue: function and physiological significance. Physiol. Rev. 84, 277–359 (2004).
Cypess, A. M. et al. Identification and importance of brown adipose tissue in adult humans. New Engl. J. Med. 360, 1509–1517 (2009).
Saito, M. et al. High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes 58, 1526–1531 (2009).
Virtanen, K. A. et al. Functional brown adipose tissue in healthy adults. New Engl. J. Med. 360, 1518–1525 (2009).
Seale, P. et al. Transcriptional control of brown fat determination by PRDM16. Cell Metab. 6, 38–54 (2007).
Kajimura, S. et al. Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-β transcriptional complex. Nature 460, 1154–1158 (2009).
Pittenger, M. F. et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143–147 (1999).
Lazarus, H. M., Haynesworth, S. E., Gerson, S. L., Rosenthal, N. S. & Caplan, A. I. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant. 16, 557–564 (1995).
Zuk, P. A. et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7, 211–228 (2001).
Barberi, T. & Studer, L. Mesenchymal cells. Methods Enzymol. 418, 194–208 (2006).
Dani, C. Embryonic stem cell-derived adipogenesis. Cells Tissues Organs 165, 173–180 (1999).
Xiong, C. et al. Derivation of adipocytes from human embryonic stem cells. Stem Cells Dev. 14, 671–675 (2005).
van Harmelen, V. et al. Differential lipolytic regulation in human embryonic stem cell-derived adipocytes. Obesity (Silver Spring) 15, 846–852 (2007).
Hannan, N. R. & Wolvetang, E. J. Adipocyte differentiation in human embryonic stem cells transduced with Oct4 shRNA lentivirus. Stem Cells Dev. 18, 653–660 (2008).
Barberi, T., Willis, L. M., Socci, N. D. & Studer, L. Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med. 2, e161 (2005).
Trivedi, P. & Hematti, P. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Exp. Hematol. 36, 350–359 (2008).
Warren, L. et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618–630 (2010).
Olivier, E. N., Rybicki, A. C. & Bouhassira, E. E. Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells. Stem Cells 24, 1914–1922 (2006).
Sen, A. et al. Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous. J. Cell Biochem. 312–319 (2001).
Tashiro, K. et al. Efficient adenovirus vector-mediated PPAR γ gene transfer into mouse embryoid bodies promotes adipocyte differentiation. J. Gene Med. 10, 498–507 (2008).
Bermingham, J. R. Jr et al. Identification of genes that are downregulated in the absence of the POU domain transcription factor pou3f1 (Oct-6, Tst-1, SCIP) in sciatic nerve. J. Neurosci. 22, 10217–10231 (2002).
Rosen, E. D. et al. PPAR γ is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 4, 611–617 (1999).
Maherali, N. et al. A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 3, 340–345 (2008).
Seale, P. et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature 454, 961–967 (2008).
Altiok, S., Xu, M. & Spiegelman, B. M. PPAR γ induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev. 11, 1987–1998 (1997).
Rosen, E. D. & MacDougald, O. A. Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell Biol. 7, 885–896 (2006).
Svensson, P. A. et al. Gene expression in human brown adipose tissue. Int. J. Mol. Med. 27, 227–232 (2011).
Tusher, V. G., Tibshirani, R. & Chu, G. Significance analysis of microarraysapplied to the ionizing radiation response. Proc. Natl Acad. Sci. USA 98, 5116–5121 (2001).
Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57 (2009).
Huang da, W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1–13 (2009).
Puigserver, P. et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829–839 (1998).
de Jesus, L. A. et al. The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue. J. Clin. Invest. 108, 1379–1385 (2001).
Zhang, Y. et al. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425–432 (1994).
Simpson, F. & Whitehead, J. P. Adiponectin—it’s all about the modifications. Int. J. Biochem. Cell Biol. 42, 785–788 (2010).
Rhee, E. P. et al. Metabolite profiling identifies markers of uremia. J. Am. Soc. Nephrol. 21, 1041–1051 (2010).
Jiao, P. et al. FFA-induced adipocyte inflammation and insulin resistance: involvement of ER stress and IKK β pathways. Obesity (Silver Spring) 19, 483–491 (2011).
Nedergaard, J., Bengtsson, T. & Cannon, B. Unexpected evidence for active brown adipose tissue in adult humans. Am. J. Physiol. Endocrinol. Metab. 293, E444–E452 (2007).
van Marken Lichtenbelt, W. D. et al. Cold-activated brown adipose tissue in healthy men. New Engl. J. Med. 360, 1500–1508 (2009).
Stadtfeld, M., Brennand, K. & Hochedlinger, K. Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Curr. Biol. 18, 890–894 (2008).
Tiscornia, G., Singer, O. & Verma, I. M. Production and purification of lentiviral vectors. Nat. Protoc. 1, 241–245 (2006).
Maherali, N. et al. A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 3, 340–345 (2008).
Maherali, N. et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1, 55–70 (2007).
Park, I. H. et al. Disease-specific induced pluripotent stem cells. Cell 134, 877–886 (2008).
Stadtfeld, M., Maherali, N., Breault, D. T. & Hochedlinger, K. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2, 230–240 (2008).
al Yacoub, N., Romanowska, M., Haritonova, N. & Foerster, J. Optimized production and concentration of lentiviral vectors containing large inserts. J. Gene Med. 9, 579–584 (2007).
Johnson, W. E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118–127 (2007).
Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57 (2009).
Rhee, E. P. et al. Metabolite profiling identifies markers of uremia. J. Am. Soc. Nephrol. 21, 1041–1051 (2010).
Acknowledgements
The authors would like to thank T. Holm, A. Foudi and E. Hanson for critical reading, insight and suggestions; M. Henderson, J. Hom, K. Hom, I. Pomerantseva, A. Tseng and K. Kulig for their technical help; L. Prickett-Rice and K. Folz-Donahue of the HSCI-CRM Flow Cytometry Core Facility; D. Lieber and V. Mootha for assistance with cellular bioenergetic measurements; and J. Truelove and R. Weissleder for assistance with PET–CT imaging. T. Ahfeldt was supported by the Roberto and Allison Mignone Fund for Stem Cell Research. This work was financially sponsored in part by the Harvard Stem Cell Institute, Hoffman-La Roche and the Stowers Medical Institute.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Information
Supplementary Information (PDF 1427 kb)
Supplementary Table 1
Supplementary Information (XLSX 320 kb)
Supplementary Table 2
Supplementary Information (XLSX 7313 kb)
Rights and permissions
About this article
Cite this article
Ahfeldt, T., Schinzel, R., Lee, YK. et al. Programming human pluripotent stem cells into white and brown adipocytes. Nat Cell Biol 14, 209–219 (2012). https://doi.org/10.1038/ncb2411
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncb2411